Barrington Research Maintains Outperform on US Physical Therapy, Maintains $108 Price Target
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and maintains $108 price target.
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and maintains $108 price target.